Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and Patients.
Journal: Clinical pharmacology and therapeutics
Published: March 26, 2025
The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers.
Journal: Journal of clinical pharmacology
Published: July 06, 2017
Comparison of the Pharmacokinetics of the Phase II and Phase III Capsule Formulations of Selumetinib and the Effects of Food on Exposure: Results From Two Randomized Crossover Trials in Healthy Male Subjects.
Journal: Clinical therapeutics
Published: February 01, 2017
Tenapanor administration and the activity of the H+ -coupled transporter PepT1 in healthy volunteers.
Journal: British journal of clinical pharmacology
Published: September 20, 2016
Effects of ranitidine (antacid), food, and formulation on the pharmacokinetics of fostamatinib: results from five phase I clinical studies.
Journal: European journal of clinical pharmacology
Published: August 23, 2016
Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials.
Journal: European journal of clinical pharmacology
Published: July 06, 2016
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.
Journal: The New England journal of medicine
Published: March 23, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026